What’s New

What's New This Year

New Companies

With 21 companies represented on the agenda, the 3rd Complement-based Drug Development Summit has the most companies you can learn from in the event’s history.

This year you can hear from the following:

  • Abvance
  • Gyroscope Therapeutics
  • Icahn School of Medicine at Mount Sinai
  • Novartis
  • NYU Langone Transplant Institute
  • Silence Therapeutics
  • Takeda
  • Vifor Pharma
  • Visterra

Speed Learning

Short yet focused sessions allowing for multiple indications and challenges to be addressed in detail. Each table will be hosted by a leader who will give a 5 minute presentation, you then get the opportunity to discuss the topic and question the host for 10 minutes before moving on to your next table.

Key Highlights:

  • Discover exciting research into astrocyte-derived extracellular vesicles as carriers of complement-mediated neurotoxicity in Alzheimer’s disease and traumatic brain injury
  • Learn about the risk of infection and how to mitigate it with Novartis
  • Discuss the availability and suitability of animal models for evaluation of complement targeting therapeutics with Visterra
  • Hear the exciting and novel work of an up-and-coming company, Abvance